Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03583996 · ClinicalTrials.gov registry record · NA
The SHUNT-V Study for Varices
A NA study, sponsored by HepQuant.
- Completed
- Registry status
- NA
- Development phase
- 306
- Enrollment target
NCT03583996 is a NA study that has completed, run by HepQuant. The registered enrollment target is 306 participants.
The verdict
NCT03583996, a NA study, has completed, sponsored by HepQuant.
- COMPLETED
- Registry status
- NA
- Development phase
- 306 participants
- Enrollment target
Study Summary
The purpose of this study is to validate the Disease Severity Index (DSI) from the HepQuant SHUNT Liver Diagnostic Kit (Test) for likelihood of large esophageal varices.
Interventions
- COMBINATION_PRODUCT HepQuant SHUNT Liver Diagnostic Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2019-01-23 |
| Est. Completion | 2022-10-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03583996
The ClinicalTrials.gov registry entry for NCT03583996 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HepQuant, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HepQuant SHUNT Liver Diagnostic Test is the first listed.
NCT03583996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03583996 about?
NCT03583996 is a clinical study titled "The SHUNT-V Study for Varices". The purpose of this study is to validate the Disease Severity Index (DSI) from the HepQuant SHUNT Liver Diagnostic Kit (Test) for likelihood of large esophageal varices.
What is the current status of trial NCT03583996?
This trial is currently completed. It is a NA study. The enrollment target is 306 participants. The study started on 2019-01-23. Estimated completion is 2022-10-22.
What interventions are being tested in trial NCT03583996?
The interventions under investigation include: HepQuant SHUNT Liver Diagnostic Test (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03583996?
This trial is sponsored by HepQuant, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.